advertisement
CAT-152 0102 Trabeculectomy Study Group 1
Showing records 1 to 1 | Display all abstracts from CAT-152 0102 Trabeculectomy Study Group20043 A phase III study of subconjunctival human anti-transforming growth factor β2 monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
CAT-152 0102 Trabeculectomy Study Group; Khaw P; Grehn F; Holló G; Overton B; Wilson R; Vogel R; Smith Z
Ophthalmology 2007; 114: 1822-1830
